Retinal degenerative diseases pose a serious threat to eye health, but there is currently no effective treatment available. Recent years have witnessed rapid development of several cutting edge technologies, such as gene therapy, stem cell therapy, and tissue engineering. Due to the special features of ocular structure, some of these technologies have been translated into ophthalmological clinic practice with fruitful achievements, setting a good example for other fields. This paper reviews the development of the gene and stem cell therapies in ophthalmology.
基金：
Beijing Commission of Education Science Technology Development Key Project [KZ201010025019]; Institute of Ophthalmology, Capital Medical Uni Project [201205]
第一作者机构：[1]Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Inst Ophthalmol, Beijing 100005, Peoples R China
通讯作者：
通讯机构：[1]Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Inst Ophthalmol, Beijing 100005, Peoples R China[*1]Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Inst Ophthalmol, 17 Hou Gou Lane, Beijing 100005, Peoples R China
推荐引用方式(GB/T 7714)：
Zhang Jing-Xue,Wang Ning-Li,Lu Qing-Jun.Development of gene and stem cell therapy for ocular neurodegeneration[J].INTERNATIONAL JOURNAL OF OPHTHALMOLOGY.2015,8(3):622-630.doi:10.3980/j.issn.2222-3959.2015.03.33.
APA：
Zhang, Jing-Xue,Wang, Ning-Li&Lu, Qing-Jun.(2015).Development of gene and stem cell therapy for ocular neurodegeneration.INTERNATIONAL JOURNAL OF OPHTHALMOLOGY,8,(3)
MLA：
Zhang, Jing-Xue,et al."Development of gene and stem cell therapy for ocular neurodegeneration".INTERNATIONAL JOURNAL OF OPHTHALMOLOGY 8..3(2015):622-630
